Piper Sandler raised the firm’s price target on Guardant Health (GH) to $120 from $90 following quarterly results. The firm keeps an Overweight rating on the shares.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health Completes $402.5M Convertible Notes Offering
- Cathie Wood Buys the Dip in Pinterest (PINS), Sells Roku and Robinhood Stocks
- Guardant Health announces Shield blood-based screening test results
- Guardant Health 3.33M share Spot Secondary priced at $90.00
- Guardant Health announces $250M common stock offering